Literature DB >> 12806236

Eosinophilic pleural effusions.

Ioannis Kalomenidis1, Richard W Light.   

Abstract

Eosinophilic pleural effusions, defined as a pleural effusion that contains at least 10% eosinophils, may be caused by almost every condition that can cause pleural disease. Eosinophilic pleural effusion occurs most commonly during conditions associated with the presence of blood or air in the pleural space, infections, and malignancy. Drug-induced pleural effusions, pleural effusions accompanying pulmonary embolism, and benign asbestos pleural effusions are also among the common causes of eosinophilic pleural effusion. No etiology is found in as many as one third of patients. Because studies evaluating different diagnostic approaches with eosinophilic pleural effusions are lacking, the authors suggest that certain noninvasive and invasive diagnostic tools must be used based on the patient's clinical characteristics.

Entities:  

Mesh:

Year:  2003        PMID: 12806236     DOI: 10.1097/00063198-200307000-00002

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  22 in total

1.  Successful treatment of eosinophilic pleural effusions following congenital heart surgery.

Authors:  G S Perens; K M Shannon; D S Levi; S Drant
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

2.  Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

Authors:  Georgios T Stathopoulos; Taylor P Sherrill; Sophia P Karabela; Kasia Goleniewska; Ioannis Kalomenidis; Charis Roussos; Barbara Fingleton; Fiona E Yull; R Stokes Peebles; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-01       Impact factor: 21.405

3.  Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces.

Authors:  Sotirios Zarogiannis; Ioannis Psallidas; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Ioannis Kalomenidis
Journal:  J Physiol Sci       Date:  2010-04-10       Impact factor: 2.781

Review 4.  Spectrum of Eosinophilic End-Organ Manifestations.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Immunol Allergy Clin North Am       Date:  2015-06-17       Impact factor: 3.479

5.  Eosinophilic pleural effusion: a rare manifestation of hypereosinophilic syndrome.

Authors:  Ndubuisi C Okafor; Ayodeji A Oso; Amanke C Oranu; Steven M Wolff; John J Murray
Journal:  Case Rep Med       Date:  2010-01-12

6.  Warfarin-induced eosinophilic pleural effusion.

Authors:  Yong-Min Jo; Tae-Ho Park; Il-Hwan Jeong; Hyun-Jeong Kim; Ji-Hye Ahn; Woo-Jae Kim; Young-Rak Cho; Hee-Kyung Baek; Moo-Hyun Kim; Young-Dae Kim
Journal:  Korean Circ J       Date:  2011-02-28       Impact factor: 3.243

7.  Use of anabolic-androgenic steroids masking the diagnosis of pleural tuberculosis: a case report.

Authors:  Carlos Fernández de Larrea; Aglae Duplat; Ismar Rivera-Olivero; Jacobus H de Waard
Journal:  J Med Case Rep       Date:  2009-01-28

8.  Mesalamine-induced eosinophilic pleural effusion.

Authors:  Abdullah Al-Abcha; Fazal Raziq; Shouq Kherallah; Ahmad Alratroot
Journal:  BMJ Case Rep       Date:  2020-04-16

9.  Cutaneous myiasis with eosinophilic pleural effusion: A case report.

Authors:  Tao Fan; Yu Zhang; Yan Lv; Jing Chang; Brent A Bauer; Juan Yang; Cheng-Wei Wang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

10.  Histiocytic pleural effusion: the strong clue to malignancy.

Authors:  Ganghee Chae; Jae-Bum Jun; Hwa Sik Jung; Chui Yong Park; Jin Hyoung Kim; Byung Ju Kang; Hyeon Hui Kang; Seung Won Ra; Kwang Won Seo; Yangjin Jegal; Jong Joon Ahn; Sang Hyuk Park; Taehoon Lee
Journal:  World J Surg Oncol       Date:  2021-06-16       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.